Hence, these mutational events are thought to play a critical role in the diverging evolution between GNAS mutated lesions of intestinal subtype (and commonly wild-type KRAS) evolving into a colloid carcinoma and KRAS-mutated lesions of the gastric type evolving into tubular invasive lesions similar to cPDAC. This evidence concerns the gene KRAS and mucinous adenocarcinoma.